Who we are

For the last 10 years we have developed and manufactured lentivirus under both EMA and FDA standards as an experienced leader in the field. The lentiviral vectors produced by VIVEbiotech are administered both ex vivo and in vivo to treat a range of disorders, including haematological and solid cancers, and rare diseases.

We are a Contract Development and Manufacturing Organization (CDMO) with over 50 biotech and pharmaceutical companies worldwide that have placed their trust in us.

Corporative video

Close corporative video

A solid project with its own personality

Our roots are 100% Guipuzcoan. Since 2015 we have spearheaded the creation of an ecosystem in our region specialized in health-related biotechnology aimed at personalized precision medicine.

Our origins

Our stable international clients and large-scale projects allow us to consolidate our structure and continue to grow sustainably, positioning our company and our region at the forefront of the medicine of the future on a global level.

2004

Advanced Therapies Unit created.

2006

Good manufacturing practices (GMP) approved by the Spanish Agency for Medicine and Health Products (AEMPS).

2009

Lentivirus Vector Unit for use in research.

2012

UNE – EN ISO 9001-2008

2015

VIVEbiotech created.

VIVEbiotech through the years

US, European, Asian and Australian clients
Compliance with EMA and FDA regulations
GMP certification for clinical-grade release
7 clean rooms fully dedicated to lentivirus
One of the few companies fully focused on lentiviral vectors
Timely slot availability
Growth investment secured in 2024

Members of

Collaborate with

Project with a future

These are exciting times in the world of biotechnology and health, with realistic expectations for cures for many pathologies. VIVEbiotech is one of the players making this possible. In 2024 we secured a growth investment from Ampersand Capital Partners to expand lentiviral vector development and manufacturing capabilities.

Bolsa de medio de cultivo de VIVEbiotech

Our value

VIVEbiotech is one of the only companies in the world specialized exclusively in lentiviral vectors, backed by a team of professionals with more than 30 years of experience.

News

All the latest news and events about VIVEbiotech, to know all its projects.